Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein–Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In Vivo
Yueping Zhang(Institute of Vegetables and Flowers), Hong Shen, Bethanne M. Warrack(Bristol-Myers Squibb (United States)), Qian Ruan(Bristol-Myers Squibb (United States)), Linna Wang(Bristol-Myers Squibb (Germany)), Michael Sinz(Rutgers, The State University of New Jersey), David M. Nelson(Cancer Research UK Scotland Institute), Runlan Huo(Bristol-Myers Squibb (Germany)), Erika Panfen(Bristol-Myers Squibb (United States)), Xueqing Chen(Brigham and Women's Hospital), R. Marcus Fancher(Bristol-Myers Squibb (United States)), Jian Chen(Army Medical University), Yongjun Xue(Bristol-Myers Squibb (Germany)), Lisa J. Christopher(Bristol-Myers Squibb (United States)), Petia Shipkova(Bristol-Myers Squibb (United States))
Cited by 15
Related Papers
CYP3A4 Induction by Drugs: Correlation between a Pregnane X Receptor Reporter Gene Assay and CYP3A4 Expression in Human Hepatocytes
|Drug Metabolism and Disposition|2002|447
The asparagus genome sheds light on the origin and evolution of a young Y chromosome
|Nature Communications|2017|348
Inactivation of Cytochrome P450 3A4 by Bergamottin, a Component of Grapefruit Juice
|Chemical Research in Toxicology|1998|312
Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole
|Oncogene|2006|211
Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)
|Antimicrobial Agents and Chemotherapy|2012|186